Circulating tumor cell eradication as an intermediate efficacy end point for metastatic castration-resistant prostate cancer: Is there enough evidence?

Emmanuel S. Antonarakis

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Circulating tumor cell eradication as an intermediate efficacy end point for metastatic castration-resistant prostate cancer: Is there enough evidence?'. Together they form a unique fingerprint.